We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Exhibits Its New Generation of Sapphire Pipette Tips at MEDICA 2021

By LabMedica International staff writers
Posted on 16 Nov 2021

Greiner Bio-One (Monroe, NC, USA) exhibited its new generation of Sapphire pipette tips at MEDICA 2021, the leading international trade fair for the medical sector. More...

More than 5,000 exhibitors from 70 countries presented their newest products and ideas at this year’s MEDICA which drew 120,000 trade visitors from over 170 countries.

At MEDICA 2021, Greiner presented its new generation of Sapphire pipette tips which are perfect flexibility for laboratory liquid handling and were launched in September. The tips are made of medical polypropylene and benefit from a universal fit on most standard pipettes. They are available in standard, filter, low-retention and filter low-retention versions. By minimizing the adhesion of sample material on the inside of the tip, the low-retention surface ensures maximum precision, even with detergents and other viscous or complex samples. The filter tips reliably prevent the transfer of biological material and aerosols, without this negatively affecting the accuracy of the volume being pipetted. No additives are used when manufacturing the filters. Even after accidental contact, it is therefore possible to continue using samples. In conjunction with Sapphire pipettes, the universal tips offer a fully optimized and harmonized liquid handling solution from a single source. The new pipette tips are produced and packaged at the company’s Austrian plant in Kremsmünster, in a fully automated process that minimizes any potential risk of contamination.

Greiner also showcased its new VACUETTE Virus Stabilization Tube that supports the safe transport and storage of specimens, including COVID-19 swab samples. The company demonstrated how its VACUETTE Virus Stabilization Tube can help alleviate some of the barriers to testing for SARS-CoV-2 that laboratories are experiencing. VACUETTE Virus Stabilization Tubes are intended for the transport and storage of nasopharyngeal and oropharyngeal swab specimens. Meant for use by healthcare professionals for SARS-CoV-2 testing only, VACUETTE Virus Stabilization Tubes are made of PET with a pre-defined volume of a phosphate buffer saline solution at a pH of 7.4±0.2 to allow for the storage of the SARS-CoV-2 swab specimens for up to 72h at 4°C. The tubes are fitted with VACUETTE Safety Caps and the tube interior is sterile. The product is single use only and can be used on a single patient only. The CE-marked VACUETTE Virus Stabilization Tubes are manufactured according to Greiner’s hygienic standards.

Related Links:
Greiner Bio-One


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.